MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Stock Cash Flow
NASDAQ:MLTX - Nasdaq - KY61559X1045 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -82.74M | -44.08M | -64.51M | -53.64M | -90.84K | |||
| Depreciation Amortization | 86.60K | 13.16K | 10.00K | 0.00 | N/A | |||
| Change In Working Capital | -6.42M | -6.22M | -1.43M | 4.48M | -230.85K | |||
| Taxes Paid | N/A | 41.71K | N/A | N/A | N/A | |||
| Other non cash items | 8.61M | 7.51M | 10.03M | 13.98M | 5.00K | |||
| OPERATING CASH FLOW | -80.46M | -42.78M | -55.89M | -35.18M | -316.69K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -284.63K | -20.00K | -50.00K | N/A | |||
| Other Investing Activity | 59.23M | -24.90M | -32.32M | N/A | -115.00M | |||
| INVESTING CASH FLOW | 58.60M | -25.18M | -32.34M | -50.00K | -115.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -15.00M | 15.00M | N/A | |||
| Stock Issued/Repurchased | 83.80M | 482.45M | 50.00K | 28.26M | 117.00M | |||
| Other Financing Activity | -4.22M | -2.75M | 134.65M | 0.00 | -347.38K | |||
| FINANCING CASH FLOW | 79.57M | 479.70M | 119.69M | 43.26M | 116.65M | |||
| Exchange Rate Effect | -231.18K | -75.31K | 10.00K | 0.00 | N/A | |||
| CHANGE IN CASH | 57.48M | 411.66M | 31.47M | 8.03M | 1.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -80.46M | -42.78M | -55.89M | -35.18M | -316.69K | |||
| Capital Expenditure | N/A | -284.63K | -20.00K | -50.00K | N/A | |||
| FREE CASH FLOW | -81.09M | -43.06M | -55.91M | -35.23M | -316.69K | |||
All data in USD